A detailed history of Steward Partners Investment Advisory, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 15,726 shares of AMRN stock, worth $9,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,726
Previous 15,726 -0.0%
Holding current value
$9,278
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.82 - $1.35 $205 - $337
-250 Reduced 1.56%
15,726 $13,000
Q3 2023

Nov 13, 2023

BUY
$0.85 - $1.43 $12,325 - $20,735
14,500 Added 982.38%
15,976 $14,000
Q2 2023

Aug 14, 2023

SELL
$1.12 - $1.49 $448 - $596
-400 Reduced 21.32%
1,476 $1,000
Q1 2023

May 15, 2023

SELL
$1.19 - $2.19 $357 - $657
-300 Reduced 13.79%
1,876 $2,000
Q4 2022

Feb 15, 2023

SELL
$1.07 - $1.34 $1,070 - $1,340
-1,000 Reduced 31.49%
2,176 $2,000
Q2 2022

Aug 04, 2022

BUY
$1.13 - $3.69 $1 - $3
1 Added 0.03%
3,176 $5,000
Q4 2021

Feb 08, 2022

SELL
$3.24 - $5.18 $11,262 - $18,005
-3,476 Reduced 52.26%
3,175 $11,000
Q3 2021

Nov 12, 2021

SELL
$3.94 - $5.84 $1,162 - $1,722
-295 Reduced 4.25%
6,651 $34,000
Q2 2021

Aug 13, 2021

SELL
$4.26 - $6.5 $25,036 - $38,200
-5,877 Reduced 45.83%
6,946 $30,000
Q1 2021

May 14, 2021

BUY
$5.03 - $8.8 $33,082 - $57,877
6,577 Added 105.3%
12,823 $79,000
Q4 2020

Feb 11, 2021

SELL
$4.04 - $5.31 $49,288 - $64,781
-12,200 Reduced 66.14%
6,246 $31,000
Q1 2020

Apr 29, 2020

SELL
$4.0 - $21.53 $52,696 - $283,636
-13,174 Reduced 41.66%
18,446 $73,000
Q4 2019

Jan 17, 2020

BUY
$13.94 - $24.12 $2,021 - $3,497
145 Added 0.46%
31,620 $677,000
Q3 2019

Oct 30, 2019

BUY
$13.89 - $23.16 $102,786 - $171,384
7,400 Added 30.74%
31,475 $477,000
Q2 2019

Jul 25, 2019

BUY
$16.27 - $20.51 $391,700 - $493,778
24,075 New
24,075 $466,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.